Progressive endothelin-1 gene activation initiates chronic/end stage renal disease following experimental ischemic-reperfusion injury

This study assessed whether endothelin-1 (ET1) helps mediate post-ischemic acute kidney injury (AKI) progression to chronic kidney disease (CKD). The impact(s) of potent ETA or ETB receptor-specific antagonists (Atrasentan and BQ-788, respectively) on disease progression were assessed 24 hours or 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zager, Richard A., Johnson, Ali CM, Andress, Dennis, Becker, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788861/
https://www.ncbi.nlm.nih.gov/pubmed/23698233
http://dx.doi.org/10.1038/ki.2013.157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788861/
https://www.ncbi.nlm.nih.gov/pubmed/23698233
http://dx.doi.org/10.1038/ki.2013.157

Ejemplares similares